Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2012; 18(45): 6651-6656
Published online Dec 7, 2012. doi: 10.3748/wjg.v18.i45.6651
Published online Dec 7, 2012. doi: 10.3748/wjg.v18.i45.6651
Parameter | Five-year overall survival | Five-year disease-free survival | ||||
P value | HR | 95%CI | P value | HR | 95%CI | |
Age | 0.775 | 0.867 | 0.463-1.452 | 0.714 | 1.174 | 0.883-1.853 |
Gender | 0.456 | 1.121 | 0.569-1.867 | 0.634 | 1.126 | 0.684-1.846 |
Tumor stage | < 0.001 | 1.634 | 1.142-2.537 | < 0.001 | 1.423 | 0.784-2.161 |
Tumor grade | < 0.001 | 1.154 | 0.647-1.893 | < 0.001 | 1.023 | 0.456-1.638 |
Presence of cirrhosis | 0.542 | 1.143 | 0.647-1.784 | 0.427 | 1.321 | 0.824-1.917 |
LSD1 expression | < 0.001 | 2.456 | 1.234-3.932 | < 0.001 | 1.426 | 0.672-2.146 |
- Citation: Zhao ZK, Yu HF, Wang DR, Dong P, Chen L, Wu WG, Ding WJ, Liu YB. Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients. World J Gastroenterol 2012; 18(45): 6651-6656
- URL: https://www.wjgnet.com/1007-9327/full/v18/i45/6651.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i45.6651